Jeffrey G. Black - 15 May 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP & Chief Financial Officer
Signature
/s/ Jeffrey G. Black by Agnieszka Gallagher, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
15 May 2024
Net transactions value
-$47,699
Form type
4
Filing time
16 May 2024, 21:07:06 UTC
Previous filing
22 May 2023
Next filing
21 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 +52,631 +61% $0.000000 138,615 15 May 2024 Direct
transaction LAB Common Stock Tax liability $47,699 -18,779 -14% $2.54 119,836 15 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 -52,631 -25% $0.000000 157,895 15 May 2024 Common Stock 52,631 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 15, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023.
F2 Each RSU represents the contingent right to receive one share of the Issuer's common stock.
F3 On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and the remaining RSUs will vest in twelve equal quarterly installments thereafter.